A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.

The Norton & Elaine Sarnoff Center for Jewish Genetics is a supporting foundation of JUF, and is supported in part by the Michael Reese Health Trust.

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A radiologist examines breast X-rays after a cancer prevention medical check-up at the Ambroise Pare hospital in ...

BRCA1 and BRCA2 gene mutations increase the risk of hereditary breast cancer. Here's what you should know about the causes, ...

Inherited mutations in the gene BRCA2 significantly increase the risk of carriers to breast and ovarian cancers. BRCA2, a crucial player in the body's DNA repair system, aids in repairing damaged DNA.

Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A ...

In a new study comparing the difference in the age at breast cancer diagnosis between older and younger generations of women with the BRCA1 and BRCA2 breast cancer gene mutations, researchers from the ...

An estimated 170,000 Australians were diagnosed with cancer in 2025. Many people know the causes of cancer are partly genetic. But how do your genes, which contribute so much of what makes you you, ...

Deescalated nab-paclitaxel plus carboplatin showed higher efficacy than nab-paclitaxel plus gemcitabine in early-stage TNBC patients. BRCA1/2 mutation carriers exhibited a more pronounced pathologic ...